Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Hyperthermia”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Testing effectiveness (Phase 2)UnknownNCT04345770
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

Who this might be right for
Malignant Neoplasm of Stomach
Wuhan University 100
Not applicableLooking for participantsNCT05402839
What this trial is testing

Screening of Malignant Hyperthermia Susceptible Individuals

Who this might be right for
Malignant Hyperthermia
Peking University Third Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02530515
What this trial is testing

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
AnemiaCancer FatigueChronic Lymphocytic Leukemia+11 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT03393858
What this trial is testing

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Who this might be right for
CancerMesothelioma, Malignant
Capital Medical University 10
Not applicableStudy completedNCT05083338
What this trial is testing

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

Who this might be right for
Appendix CarcinomaCarcinomatosisColorectal Carcinoma+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00002973
What this trial is testing

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 34
Large-scale testing (Phase 3)Study completedNCT03551626
What this trial is testing

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

Who this might be right for
Malignant Melanoma
Novartis Pharmaceuticals 552
Not applicableEnded earlyNCT02964481
What this trial is testing

Malignant Hyperthermia Registry and Genetic Testing

Who this might be right for
Malignant Hyperthermia
Children's Hospital Medical Center, Cincinnati 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT01972347
What this trial is testing

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 35
Not applicableStudy completedNCT01069887
What this trial is testing

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant

Who this might be right for
Hematological MalignanciesStem Cell Transplantation
Catholic University of the Sacred Heart 3,000
Not applicableStudy completedNCT04460053
What this trial is testing

Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion.

Who this might be right for
Malignant Melanoma
Vastra Gotaland Region 18
Not applicableEnded earlyNCT02650492
What this trial is testing

Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Clinical Laserthermia Systems AB 2
Not applicableStudy completedNCT01574235
What this trial is testing

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Who this might be right for
Solid TumorsMalignant HemopathyChemotherapy-induced Febrile Neutropenia (FN)
Hospira, now a wholly owned subsidiary of Pfizer 2,114
Not applicableUnknownNCT01684189
What this trial is testing

Registry of Febrile Neutropenia and Invasive Fungal Infections

Who this might be right for
Hematological DiseaseFebrile NeutropeniaFungal Infections
Chang Gung Memorial Hospital 100
Early research (Phase 1)Study completedNCT01484015
What this trial is testing

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt Lymphoma+36 more
Wake Forest University Health Sciences 70
Early research (Phase 1)Study completedNCT00571298
What this trial is testing

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Brigham and Women's Hospital 141
Early research (Phase 1)UnknownNCT06281860
What this trial is testing

Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration

Who this might be right for
Mesothelioma, MalignantCarcinoma, Non-Small-Cell LungCarcinoma Breast Stage IV+3 more
Dr Jean Yannis PERENTES 39
Testing effectiveness (Phase 2)Study completedNCT02830139
What this trial is testing

Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer

Who this might be right for
Malignant Neoplasm of Colorectum
Wuhan University 100
Not applicableStudy completedNCT00735384
What this trial is testing

Muscle Force Assessment in the Intensive Care Unit and in Primary Myopathies

Who this might be right for
SepsisPrimary Myopathies
University Hospital, Basel, Switzerland 22
Testing effectiveness (Phase 2)UnknownNCT01838538
What this trial is testing

Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy

Who this might be right for
Ovarian Cancer With Malignant Ascites
Chinese PLA General Hospital 54
Load More Results